Shionogi Pharma, Inc. - Strategic Analysis Review
Book Details
Author(s)GlobalData
PublisherMarketResearch.com
ISBN / ASINB0042L5PSU
ISBN-13978B0042L5PS7
AvailabilityAvailable for download now
MarketplaceUnited States 🇺🇸
Description
Shionogi Pharma, Inc.(formerly Sciele Pharma, Inc.) is a subsidiary of Shionogi Inc.It is a pharmaceutical company engaged in the sales, marketing and distribution of branded prescription products of Shionogi Inc. like the cardiovascular, diabetes, pediatric and women's healthcare. The company markets and sells many products to primary care physicians, endocrinologists, cardiologists, obstetricians and gynecologists, and pediatricians.The company is mainly working from Atlanta, Georgia. The company is a US based group company of Shionogi & Co., Ltd.
Shionogi Pharma, Inc. Key Recent Developments
Apr 29, 2010: Impax Confirms Patent Challenge Relating To Fenoglide 40 And 120mg Tablets
Jan 07, 2010: Sciele Launches Adrenaclick Auto-Injector
Nov 19, 2009: Sciele Presents Data On Premature Ejaculation Drug
Oct 01, 2009: Sciele Pharma, Addrenex Submit sNDA To FDA For Clonicel
Oct 01, 2009: Addrenex Files sNDA Submission For Clonicel
GlobalData’s Shionogi Pharma, Inc. - Strategic Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Reasons to buy
Shionogi Pharma, Inc. Key Recent Developments
Apr 29, 2010: Impax Confirms Patent Challenge Relating To Fenoglide 40 And 120mg Tablets
Jan 07, 2010: Sciele Launches Adrenaclick Auto-Injector
Nov 19, 2009: Sciele Presents Data On Premature Ejaculation Drug
Oct 01, 2009: Sciele Pharma, Addrenex Submit sNDA To FDA For Clonicel
Oct 01, 2009: Addrenex Files sNDA Submission For Clonicel
GlobalData’s Shionogi Pharma, Inc. - Strategic Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - GlobalData’s summarization of the company’s business strategy.
- SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
Reasons to buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

